Navigation Links
Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
Date:7/20/2009

nts with type 2 diabetes taking stable doses of metformin alone or in combination with a sulfonylurea. Exenatide once weekly was administered once a week in a fixed dose while Lantus was administered daily in a variable dose determined by patient blood sugar levels.

"Exenatide once weekly outperformed Lantus in this superiority study by meeting its primary endpoint," stated Orville G. Kolterman, M.D., senior vice president of research and development, Amylin Pharmaceuticals. "Both treatment arms started with a baseline A1C of 8.3 percent and exenatide once weekly provided statistically significantly greater A1C reduction, weight loss versus weight gain and fewer episodes of hypoglycemia."

More than 90 percent of patients completed the study. During the 26-week treatment period, the most frequently reported adverse events were upper respiratory infection, including nasopharyngitis, in both treatment arms, as well as gastrointestinal events, including nausea, in the exenatide once weekly treatment group. Patients treated with exenatide once weekly experienced less confirmed hypoglycemia: the incidence of hypoglycemia was 4 percent with exenatide once weekly versus 19 percent with Lantus for patients on metformin background therapy, and 20 percent with exenatide once weekly versus 44 percent with Lantus for patients on metformin and a sulfonylurea background therapy, differences that are statistically significant in both treatment groups.

Study Design

The 26-week open-label, superiority study included 467 subjects with type 2 diabetes who were not achieving adequate glucose control using metformin therapy alone or in combination with a sulfonylurea. Subjects were randomized to receive exenatide once weekly 2 milligrams by subcutaneous injection weekly or insulin glargine injections administered daily in a variable dose determined by patient blood sugar levels. There was no lead-in or wash
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
2. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
3. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
4. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
5. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
6. Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
7. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
8. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
9. Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
10. Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009
11. The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 When staff from a ... apply the difficult to adjust and uncomfortable cubital ... Professional Products, Inc. (PPI) to develop a superior ... orthopaedic solutions for nearly five decades, responded with ... ), which it announced today. Simple to ...
(Date:12/14/2009)... Dec. 14 ... a leading provider of tools and services for ... that it has completed the sale of Xenogen ... pre-clinical CRO services, to Taconic Farms, Inc. for ... Caliper as part of Caliper,s acquisition of Xenogen ...
(Date:12/14/2009)... Dec. 14 Travelers of Interstate 70 west ... become a bit more colorful when 10 multicolored art ... is named going home , will eventually include ... a graduate student at Herron School of Art and ... Public Life. ,, Eli Lilly and Company (NYSE: ...
Breaking Medicine Technology:New Cubital Tunnel Splint Specially Designed for Comfort and Less Cumbersome Fit 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4BIA Publishes White Paper 3A ISO 9000 Role in Document Review Emphasizes Quality Equals Defensibility 5183 1BIA Publishes White Paper 3A ISO 9000 Role in Document Review Emphasizes Quality Equals Defensibility 5183 2BIA Publishes White Paper 3A ISO 9000 Role in Document Review Emphasizes Quality Equals Defensibility 5183 3Glove Nation Launches Major Website Upgrade 14329 1Glove Nation Launches Major Website Upgrade 14329 2High Cost of Chronic Illness Spotlights Need for Case Management Professionals 58738 1High Cost of Chronic Illness Spotlights Need for Case Management Professionals 58738 2
... Proof-of-Principle Studies -, GAITHERSBURG, Md., April 3, ... announced that it has signed an agreement,with Merck ... the use of the Iomai needle-free immunostimulant patch., ... exclusive license. These,preclinical proof-of-principle studies will be conducted ...
... announced a,cash injection from Midroc New Technology AB who ... will be used for,the further development of DermaGen,s first ... clinical phase 2a study in patients with Atopic,Dermatitis (AD), ... further develop the company,s R & D pipeline., ...
Other Medicine Technology:Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 3DermaGen AB Receives Over 1 Million Euros From a New Share Issue 2DermaGen AB Receives Over 1 Million Euros From a New Share Issue 3
(Date:12/14/2009)... 15 In today,s academic medical centers, ... ever. Now the University HealthSystem Consortium (UHC) has ... Analysis: Achieving Cost Efficiencies in Health Care, ... environments. These new materials, developed with the input ... a practical guide to planning, implementing, and managing ...
(Date:12/14/2009)... ATLANTA, Dec. 14 Americold Realty Trust ("Americold") ... on Form S-11 with the U.S. Securities and Exchange ... offering of its common shares. The number of shares ... offering have not yet been determined. The common shares ... be sold by Americold. ,, The joint book-running ...
(Date:12/14/2009)... Dental Care (also known as Culver City Dentist ... care in Southern California. We provide treatments in general ... and periodontal treatments. Beverly Hills Dentist and ... with experienced and trusted dentists who provide these treatments ... is one of these trusted dentists. He is best ...
(Date:12/14/2009)... Sedwitz Heads up 900-Member Physician Staff , ... La ... Jolla have elected Marc Sedwitz, MD, as the new chief of ... head of the 900-member physician team on Jan. 1, 2010. , ... as medical staff liaison to Scripps La Jolla’s administrative staff and ...
(Date:12/14/2009)... Calif., Dec. 14 Grubb & Ellis Healthcare REIT ... authorized a daily distribution to stockholders of record as of ... commencing on Jan. 1, 2010 and ending on Feb. 28, ... days in the calendar year and will be equal to ... price of $10.00 per share. These distributions will be ...
Breaking Medicine News(10 mins):Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:United Dental Care, Gentle Care, Trusted Dentists 2Health News:United Dental Care, Gentle Care, Trusted Dentists 3Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3
... 4 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :,HAE), ... plasma-derived protein products for commercialization,announces that it ... fractionation,facility for the production of its proprietary ... clinical trials, leading to commercial launch., ...
... BasicPlus Health,Insurance of Roswell, Ga., announced today that ... Healthcare Inc. of Columbia, S.C., to,include a network ... benefit health insurance plans., The agreement means ... (for individuals) limited benefit plans have the,option of ...
... New e-book outlines major issues and best practices for handling fresh, produce ... ... to know., ATLANTA, June 4 Fresh ... have raised public awareness and,industry concern. At its biennial meeting in San ...
... Bethesda, MD The American Society for Investigative ... M. Engman, MD, PhD, Professor of Pathology and ... of the ASIP - Amgen Outstanding Investigative Award, ... experimental pathology funded by Amgen. Dr. Engman ...
... Licensed pesticide applicators who used chlorinated pesticides on more ... risk of diabetes, according to researchers from the National ... and incident diabetes ranged from a 20 percent to ... with the NIH,s National Institute of Environmental Health Sciences ...
... Unilens Vision Inc. (OTC,Bulletin Board: UVICF; ... distributes and markets specialty contact lenses,today revealed ... GP (Gas Permeable),products., Unilens, known as ... continues its tradition of providing outstanding programs,designed ...
Other Medicine News:Health News:Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 3Health News:Chemstar Corporation Publishes New Insights on Fresh Produce Safety From CFP Workshop 2Health News:Long-term pesticide exposure may increase risk of diabetes 2Health News:Long-term pesticide exposure may increase risk of diabetes 3Health News:Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability 2
The TEW Cranial/Spinal Retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required....
... Infuse Bone Graft represents an rhBMP-2 ... combined with a bovine-derived absorbable collagen sponge ... tapered fusion device is indicated for spinal ... degenerative disc disease (DDD) at one level ...
... dowels are threaded to dramatically ... and improve graft stability. Dense, ... blood cell saturation for osteogenesis. ... into the porous structure of ...
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
Medicine Products: